Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology research

FHS
May 1, 2024
2:19 pm

IGC Pharma heads towards a Phase I study for Alzheimer’s disease – Pharmaceutical Technology

Share this article TGR-63, being developed to target amyloid-beta plaques, has shown preclinical potential in reducing Alzheimer’s-related anxiety. Credits: AtlasStudio/Shutterstock.com With positive preclinical data for

February 2, 2024

Azenta opens the doors to its new genomics laboratory in Oxford, UK

Azenta, Inc. today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further

May 16, 2024

Meta Title: “Precigen Inc Patent: Insect Population Control with Lethal Gene Expression

Share this article According to GlobalData’s company profile on Precigen, Cancer treatment biomarkers was a key innovation area identified from patents. Precigen‘s grant share as

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.